Pharma Pulse
search-icon

Tag: Ulipristal acetate

I-Pill (Levonorgestrel) vs Alternatives: A Practical Comparison

I-Pill (Levonorgestrel) vs Alternatives: A Practical Comparison

Posted On October 25, 2025 10

A clear, side‑by‑side comparison of the I‑Pill (levonorgestrel) with Ulipristal, copper IUD, and Yuzpe regimen, covering effectiveness, side‑effects, and when to use each.

MOST POPULAR

Allergy Medications: Antihistamines and Decongestants Risks You Can't Ignore

Allergy Medications: Antihistamines and Decongestants Risks You Can't Ignore

Posted On December 1, 2025
FDA Listing for Biosimilars: How They Are Evaluated and Approved

FDA Listing for Biosimilars: How They Are Evaluated and Approved

Posted On December 15, 2025
Contact Dermatitis: How to Identify and Avoid Allergens That Trigger Your Skin Rash

Contact Dermatitis: How to Identify and Avoid Allergens That Trigger Your Skin Rash

Posted On January 18, 2026
Dermatomyositis and Polymyositis: Understanding Muscle Inflammation and Modern Treatment Options

Dermatomyositis and Polymyositis: Understanding Muscle Inflammation and Modern Treatment Options

Posted On November 28, 2025
Tadora Tablets: Uses, Effects, Safe Dosage and Essential Information

Tadora Tablets: Uses, Effects, Safe Dosage and Essential Information

Posted On June 24, 2025

Categories

  • Health (140)

ARCHIVES

  • January 2026 (17)
  • December 2025 (29)
  • November 2025 (18)
  • October 2025 (30)
  • September 2025 (15)
  • August 2025 (7)
  • July 2025 (12)
  • June 2025 (11)
  • May 2025 (6)
Pharma Pulse

Menu

  • About Pharma Pulse Weekly
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact Us

Recent Posts

Allergy Medications: Antihistamines and Decongestants Risks You Can't Ignore

Allergy Medications: Antihistamines and Decongestants Risks You Can't Ignore

Posted On December 1, 2025
FDA Listing for Biosimilars: How They Are Evaluated and Approved

FDA Listing for Biosimilars: How They Are Evaluated and Approved

Posted On December 15, 2025
© 2026. All rights reserved.